News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

Azurity Pharmaceuticals has earned FDA approval for Danziten (nilotinib), a new formulation of Novartis’ chronic myeloid ...

Combination of ziftomenib and imatinib shows robust and durable antitumor activity in imatinib-sensitive (1L) and imatinib-resistant (2L/3L) GIST models – – Proof-of-concept study of ziftomenib plus ...

Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a Late-Stage Clinical Trial Program in Pulmonary ...

What is patent evergreening and what does the Indian patent regime tell us about it? Also, go beyond the nugget to know about ...

Chronic myeloid leukaemia (CML) blockbuster Gleevec has been badly hit by generic competition in the US, revenues falling 30% to $834 million in the period. This decline will continue, with ...

Two generic drugmakers, Apotex and Heritage Pharmaceuticals, have agreed to pay a combined $49 million to settle allegations they fixed prices on numerous medicines, the first such agreements ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The European Commission has fined Teva, the world’s largest generic drugmaker, €462.6mn for hindering ...

By Bulto’s estimate, some 30% to 40% of first-line patients today are being treated with Gleevec or generic imatinib. Novartis expects the first adopters of Scemblix in first-line CML will be ...

Investigators had to select the TKI they would give patients, either Novartis' Gleevec (imatinib) or a second generation TKI, before patients were randomized in the trial. When investigators looked at ...

The accelerated approval is based on major molecular response rate (MMR) at week 48 from the ASC4FIRST Phase III trial that compared once daily Scemblix to all other investigator-selected (IS) ...

German HPC vendor ParTec is taking legal action against Nvidia for alleged patent infringement, seeking an injunction to stop its GPUs being sold in 18 countries that are participants in the ...